Introducing...
electronRx delivers clinically validated digital biomarkers and continuous patient insights across COPD, Asthma, Interstitial Lung Disease and Pulmonary Hypertension, accelerating drug development, patient stratification, and real world outcomes.
purpleDx is a cardiopulmonary assessment device built to medical-grade standards, enabling patients to measure lung function leading to enhanced patient outcomes.
purpleDx: Medical Grade Digital Biomarker Solution
Captures the physiological cardiopulmonary metrics :
Heart Rate
Respiratory Rate
Tidal Volume
Why purpleDx?
purpleDx: Clinical Innovation
purpleDx is a medical tool, with potential applications in detecting, monitoring, and treating respiratory diseases. This device aims to improve patient outcomes and optimise drug efficacy.
Integrating digital biomarker monitoring with prescribed medications embodies a progressive approach to healthcare management. purpleDx's cutting-edge technology allows healthcare providers to gain access to real-time physiological data via the clinical dashboard. Enabling clinicians to customise patient treatment plans, resulting in improved treatment results.
purpleDx represents a forward thinking approach to respiratory care, bridging digital health innovation with pharmaceutical precision.
Dr. Andy Potter
Whaddon Medical Centre
“Emerging technologies offer promising solutions for better asthma management. These tools can help identify patients at risk of severe asthma attacks, enabling timely interventions and reducing hospital admissions”
